Novartis has just published its Corporate Responsibility (CR) Performance Report for 2014.
The organisation, which has a strong history of CR activities, offers additional historical data, context and consolidation on the company's CR data in the report. The new report is structured in accordance with the Global Reporting Initiative’s G4 guidelines and fulfills Novartis' commitment to producing a UNGC Communication on Progress.
Some of the achievements for 2014 include:
- Reduced greenhouse gas emissions by 12.1% since 2008, despite the Novartis business growing by 21% in the same period
- Strengthened governance of CR through formation of the Governance, Nomination and Corporate Responsibilities Committee of the Board of Directors to oversee Novartis’ strategy and governance on CR-related issues
- Established a dedicated Access to Medicine Committee to advance the goal of making healthcare more accessible to more people
- Trained more than 122,000 Novartis associates on the company’s Code of Conduct